|
1
|
Sørlie T, Perou CM, Tibshirani R, et al:
Gene expression patterns of breast carcinomas distinguish tumor
subclasses with clinical implications. Proc Natl Acad Sci USA.
98:10869–10874. 2001.PubMed/NCBI
|
|
2
|
Sørlie T, Tibshirani R, Parker J, et al:
Repeated observation of breast tumor subtypes in independent gene
expression data sets. Proc Natl Acad Sci USA. 100:8418–8423.
2003.PubMed/NCBI
|
|
3
|
Parker JS, Mullins M, Cheang MC, et al:
Supervised risk predictor of breast cancer based on intrinsic
subtypes. J Clin Oncol. 27:1160–1167. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nielsen TO, Hsu FD, Jensen K, et al:
Immunohistochemical and clinical characterization of the basal-like
subtype of invasive breast carcinoma. Clin Cancer Res.
10:5367–5374. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cheang MCU, Chia SK, Voduc D, et al: Ki67
index, HER2 status, and prognosis of patients with luminal B breast
cancer. J Natl Cancer Inst. 101:736–750. 2009. View Article : Google Scholar
|
|
6
|
Jaenisch R and Bird A: Epigenetic
regulation of gene expression: how the genome integrates intrinsic
and environmental signals. Nat Genet. 33:245–254. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dworkin AM, Huang TH and Toland AE:
Epigenetic alterations in breast: Implications for breast cancer
detection, prognosis and treatment. Semin Cancer Biol. 19:165–171.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Widschwendter M and Jones PA: DNA
methylation and breast carcinogenesis. Oncogene. 21:5462–5482.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bediaga N, Acha-Sagredo A, Guerra I, et
al: DNA methylation epigenotypes in breast cancer molecular
subtypes. Breast Cancer Res. 12:R772010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Holm K, Hegardt C, Staaf J, et al:
Molecular sybtypes of breast cancer are associated with
characteristic DNA methylation patterns. Breast Cancer Res.
12:R362010. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Goldhirsch A, Wood WC, Coates AS, et al:
Strategies for subtypes - dealing with the diversity of breast
cancer: highlights of the St. Gallen International Expert Consensus
on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol.
22:1736–1747. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang DW, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
Bioinformatics Resources. Nat Protoc. 4:44–57. 2009.PubMed/NCBI
|
|
13
|
Wang S, Dorsey TH, Terunuma A, Kittles RA,
Ambs S and Kwabi-Addo B: Relationship between tumor DNA methylation
status and patient characteristics in African-American and
European-American women with breast cancer. PLoS One.
7:e379272012.PubMed/NCBI
|
|
14
|
Rattner A, Hsieh JC, Smallwood PM, et al:
A family of secreted proteins contains homology to the
cysteine-rich ligand-binding domain of frizzled receptors. Proc
Natl Acad Sci USA. 94:2859–2863. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Finch PW, He X, Kelley MJ, et al:
Purification and molecular cloning of a secreted, Frizzled-related
antagonist of Wnt action. Proc Natl Acad Sci USA. 94:6770–6775.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cadigan KM and Nusse R: Wnt signaling: a
common theme in animal development. Genes Dev. 11:3286–3305. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Polakis P: Wnt signaling and cancer. Genes
Dev. 14:1837–1851. 2000.
|
|
18
|
Ugolini F, Adélaïde J, Charafe-Jauffret E,
et al: Differential expression assay of chromosome arm 8p genes
identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth
Factor Receptor 1 (FGFR1) as candidate breast cancer genes.
Oncogene. 18:1903–1910. 1999. View Article : Google Scholar
|
|
19
|
Klopocki E, Kristiansen G, Wild PJ, et al:
Loss of SFRP1 is associated with breast cancer progression and poor
prognosis in early stage tumors. Int J Oncol. 25:641–649.
2004.PubMed/NCBI
|
|
20
|
Liedtke C, Ruckert C, Goette M, et al:
Secreted frizzled receptor protein 1 (sFRP-1) as both a potential
novel biomarker of triple negative breast cancer (TNBC), and its
sensitivity against taxane/anthracycline containing neoadjuvant
chemotherapy. Cancer Res. 69(24 Suppl): 40472009. View Article : Google Scholar
|
|
21
|
Veeck J, Niederacher D, An H, Klopocki E,
et al: Aberrant methylation of the Wnt antagonist SFRP1 in breast
cancer is associated with unfavourable prognosis. Oncogene.
25:3479–3488. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fiegl H, Millinger S, Goebel G, et al:
Breast cancer DNA methylation profiles in cancer cells and tumor
stroma: association with HER-2/neu status in primary breast cancer.
Cancer Res. 66:29–33. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Celebiler CA, Kilic Y, Saydam S, et al:
Predicting invasive phenotype with CDH1, CDH13, CD44, and TIMP3
gene expression in primary breast cancer. Cancer Sci.
100:2341–2345. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hinshelwood RA and Clark SJ: Breast cancer
epigenetics: normal human mammary epithelial cells as a model
system. J Mol Med. 86:1315–1328. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lo PK and Sukumar S: Epigenomics and
breast cancer. Pharmacogenomics. 9:1879–1902. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Feng W, Shen L, Wen S, et al: Correlation
between CpG methylation profiles and hormone receptor status in
breast cancers. Breast Cancer Res. 9:R572007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Eisen MB, Spellman PT, Brown PO and
Botstein D: Cluster analysis and display of genome-wide expression
patterns. Proc Natl Acad Sci USA. 95:14863–14868. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yuan Y, Mendez R, Sahin A and Dai JL:
Hypermethylation leads to silencing of the SYK gene in human breast
cancer. Cancer Res. 61:5558–5561. 2001.PubMed/NCBI
|
|
29
|
Raish M, Dhillon VS, Ahmad A, et al:
Promoter hypermethylation in tumor suppressing genes p16 and FHIT
and their relationship with estrogen receptor and progesterone
receptor status in breast cancer patients from Northern India.
Transl Oncol. 2:264–270. 2009. View Article : Google Scholar
|
|
30
|
Du Y, Carling T, Fang W, Piao Z, Sheu JC
and Huang S: Hypermethylation in human cancers of the RIZ1 tumor
suppressor gene, a member of a histone/protein methyltransferase
superfamily. Cancer Res. 61:8094–8099. 2001.PubMed/NCBI
|
